These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7527170)

  • 1. Lomefloxacin prophylaxis in visual laser ablation of the prostate.
    Costa FJ
    Urology; 1994 Dec; 44(6):933-6. PubMed ID: 7527170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holmium laser resection of the prostate versus neodymium:yttrium-aluminum-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy.
    Gilling PJ; Cass CB; Malcolm A; Cresswell M; Fraundorfer MR; Kabalin JN
    Urology; 1998 Apr; 51(4):573-7. PubMed ID: 9586609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual laser ablation of the prostate: a preliminary report.
    Malek RS; Barrett DM; Dilworth JP
    Mayo Clin Proc; 1995 Jan; 70(1):28-32. PubMed ID: 7528865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual laser ablation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia.
    Uchida T; Ohori M; Iwamura M; Egawa S; Ao T; Yokoyama E; Mashimo S; Endo T; Koshiba K
    Int J Urol; 1996 Jan; 3(1 Suppl):S55-9. PubMed ID: 24304026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis in transurethral surgery: oral lomefloxacin versus intravenous cefuroxime.
    Martín-Luengo F; Fontana L; Rico JL; Tomás-Ros M; Murcia A; Romero A
    Methods Find Exp Clin Pharmacol; 1993; 15(1):57-9. PubMed ID: 8386794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime.
    Crawford ED; Berger NS; Davis MA; Donohue RE
    J Urol; 1992 Apr; 147(4):1053-5. PubMed ID: 1313116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary tract infection prophylaxis in transurethral surgery: oral lomefloxacin versus parenteral cefuroxime.
    Charton M; Mombet A; Gattegno B
    Am J Med; 1992 Apr; 92(4A):118S-120S. PubMed ID: 1316060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual laser ablation of the canine prostate with a diffusing fiber and an 805-nanometer diode laser.
    Cromeens DM; Johnson DE; Stephens LC; Gray KN
    Lasers Surg Med; 1996; 19(2):135-42. PubMed ID: 8887915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual laser ablation of the prostate (VLAP): an effective alternative treatment of benign prostatic hyperplasia.
    Mattelaer P; Jung P; Wolff J; Jakse G
    Acta Urol Belg; 1995 Sep; 63(3):45-9. PubMed ID: 7484522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter comparison of oral lomefloxacin versus parenteral cefotaxime as prophylactic agents in transurethral surgery.
    Klimberg IW; Childs SJ; Madore RJ; Klimberg SR
    Am J Med; 1992 Apr; 92(4A):121S-125S. PubMed ID: 1316061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies on advantages and safety of visual laser ablation for patients with benign prostatic hyperplasia.
    Nasu Y; Watanabe T; Kumon H; Ohmori H
    Int J Urol; 1996 Jan; 3(1 Suppl):S53-4. PubMed ID: 24304025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised prospective trial of contact laser prostatectomy (CLAP) versus visual laser coagulation of the prostate (VLAP) for the treatment of benign prostatic hyperplasia. 2-year follow-up.
    Bryan NP; Hastie KJ; Chapple CR
    Eur Urol; 2000 Sep; 38(3):265-71. PubMed ID: 10940699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy alone.
    Planz B; Kalem T; Sprenger C; Deix T; Djavan B; Hanke P
    Urol Int; 2003; 71(1):26-30. PubMed ID: 12845256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neodymium:YAG laser ablation of the prostate gland--acute perioperative morbidity and short-term outcome.
    Egawa S; Uchida T; Kawakami T; Yokoyama E; Koshiba K
    Int J Urol; 1994 Sep; 1(3):246-51. PubMed ID: 7542155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of a benign prostatic hyperplasia by Nd:YAG laser - own experience.
    Pypno W; Husiatynski W
    Eur Urol; 2000 Aug; 38(2):194-8. PubMed ID: 10895012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E
    Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.